Pharmacological investigations of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine.
D000135:Acid Phosphatase / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000008:administration & dosage*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000917:Antibody Formation / Q000187:drug effects*; D001241:Aspirin / Q000008:administration & dosage; D001792:Blood Platelets / Q000187:drug effects; D001798:Blood Proteins / Q000032:analysis; D002449:Cell Aggregation / Q000187:drug effects; D003520:Cyclophosphamide / Q000008:administration & dosage; D003864:Depression, Chemical; D005342:Fibrinolysis / Q000187:drug effects*; D005439:Flufenamic Acid / Q000008:administration & dosage; D005966:Glucuronidase / Q000037:antagonists & inhibitors; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects*; D006854:Hydrocortisone / Q000008:administration & dosage; D007213:Indomethacin / Q000008:administration & dosage; D007249:Inflammation / Q000097:blood; D008297:Male; D008528:Mefenamic Acid / Q000008:administration & dosage; D051379:Mice; D010653:Phenylbutazone / Q000008:administration & dosage; D011485:Protein Binding / Q000187:drug effects*; D011489:Protein Denaturation / Q000187:drug effects; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001798:Blood Proteins; D011725:Pyridines; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D003520:Cyclophosphamide; D000135:Acid Phosphatase; D005966:Glucuronidase; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin